Combinatorial inhibition of HDACs and Hedgehog pathway synergistically suppresses tumor growth and homologous recombination in aerodigestive cancers, and a dual-targeted inhibitor is capable of effectively overcoming the Smo inhibitor resistance conferred by Smo mutations [74, 75]. This evidence concerns the gene SMO and neoplasm.